Key result
Most arrhythmias during pregnancy are benign and require no intervention; when required, treatment should be based on symptom severity and associated risks to mother and fetus.
This review emphasizes that arrhythmia management in pregnancy should be symptom-driven and carefully weigh risks to both mother and fetus, avoiding empiric therapy.
Favors symptom-driven arrhythmia care in pregnancy; leaves open prospective validation of fetal risk thresholds.
This paper reviews current recommendations on the appropriate evaluation and management of cardiac arrhythmias in the pregnant patient. Most arrhythmias during pregnancy are benign and require no intervention. When required, the decision to treat should be based on symptom severity and the associated risk to mother and fetus posed by potentially recurring arrhythmia episodes throughout the pregnancy. Any treatment strategy in this patient population has inherent risk to both mother and unborn child. Before the initiation of any intervention, documentation of a clinical arrhythmia and correlation with clinical symptoms should be obtained. There is no role for empiric therapy.
No takes yet. Share an insight, caveat, or question.
Burkart et al. (2016) conducted a review in Cardiac arrhythmias during pregnancy. Arrhythmia management was evaluated. Most arrhythmias during pregnancy are benign and require no intervention; when required, treatment should be based on symptom severity and associated risks to mother and fetus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: